BrainBits

Springfield, United States Founded: 1999 • Age: 27 yrs Acquired By Transnetyx
Developer of micro-surgically dissected, live brain tissues from rats and mice for pharmaceutical use
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 2 Known backers
Products 6 Services tracked
Competitors 10 Brand Intelligence

About BrainBits

BrainBits is a company based in Springfield (United States) founded in 1999 by Bob Bean was acquired by Transnetyx in February 2021. BrainBits offers products and services including Mouse Tissue, Rat Tissue, Growth Media, Microglia Cells, and Cardiomyocytes. BrainBits operates in a competitive market with competitors including Biocytogen, Interius Biotherapeutics, Applied StemCell, GenOway and Champion Oncology, among others.

  • Headquarter Springfield, United States
  • Founders Bob Bean
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Brainbits
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Transnetyx

    & 1 more

  • Employee Count
    Not available
  • Acquired by
    Transnetyx

    & 1 more

    (Feb 08, 2021)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of BrainBits

BrainBits offers a comprehensive portfolio of products and services, including Mouse Tissue, Rat Tissue, Growth Media, Microglia Cells, and Cardiomyocytes.

Product name locked
Category locked
Primary

Fresh tissue from mice for neuroscience studies

Product name locked
Category locked
Locked

Fresh tissue from rats for biological research

Product name locked
Category locked
Locked

Media for cell growth and storage in experiments

Product name locked
Category locked
Locked

Cells for immune and brain research applications

Product name locked
Category locked
Locked

Heart cells for cardiovascular studies

Product name locked
Category locked
Locked

Cryopreservation medium for long-term cell storage

Funding Insights of BrainBits

Premium access

Detailed funding history for BrainBits

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in BrainBits

BrainBits has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Transnetyx and MPG Equity Partners.

All
Venture Fund
Investor Description Founded Year Domain Location
Private equity firm focused on acquiring Midwestern US businesses.
Locked Locked Locked
Automated genotyping services for murine cell lines are developed.
Locked Locked Locked
Premium access

Investor details for BrainBits

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by BrainBits

Investments
Premium access

Investment portfolio details for BrainBits

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - BrainBits

Premium access

Detailed financials for BrainBits

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Brainbits Comparisons

BrainBits Primary company
Description
Developer of micro-surgically dissected, live brain tissues ...
Location
Springfield, United States
Founded Year
1999
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for BrainBits

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of BrainBits

BrainBits operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biocytogen, Interius Biotherapeutics, Applied StemCell, GenOway and Champion Oncology, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Integrated solutions for next-generation antibody drug development are provided.
Locked Locked Locked
Developer of gene therapies for treating multiple diseases
Locked Locked Locked
Provider of animal and cell line models as tools for drug discovery and diagnostics
Locked Locked Locked
Provider of transgenic rodent models and customized cell lines for preclinical development
Locked Locked Locked
Drug response assays are performed using murine in vivo models.
Locked Locked Locked
Provides 3D tumor models and assays for cancer research and preclinical testing services.
Premium access

Detailed competitors of BrainBits

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Brainbits

Premium access

Complete news archive for BrainBits

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about BrainBits

BrainBits was founded in 1999.

BrainBits is headquartered in Springfield, United States.

BrainBits was founded in 1999 in Springfield, United States, focusing on the biotechnology sector for neuroscience research. Live brain structures from embryonic rats and mice are micro-surgically dissected and preserved in nutrient media like Hibernate. Tissue procurement processes are facilitated to enable precise selection from animal cells. Complete cell culturing kits, cardiomyocytes, growth media, and microglia are offered to support pharmaceutical and research applications.

BrainBits's top competitors include Biocytogen, Applied StemCell and GenOway.

BrainBits offers Mouse Tissue, Rat Tissue, Growth Media, Microglia Cells, and 2 more products and services.

BrainBits has 2 investors. Key investors include Transnetyx, and MPG Equity Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available